Download PDF Flyer
Volume: 3
Co-Editor(s): Atta-ur-Rahman and Allen B. Reitz
DOI: 10.2174/97816080520661060301 eISBN: 978-1-60805-206-6, 2006 ISBN: 978-1-60805-674-3 ISSN: 1567-2042 (Print) ISSN: 1875-5763 (Online)
Indexed in: Scopus, EMBASE, Chemical Abstracts, EBSCO, Ulrich's Periodicals Directory.
Recommend this Book to your Library
Frontiers in Medicinal Chemistry is a book series devoted to the review of areas of important topical interest to medicinal chemists and others in allied disciplines. Frontiers in Medicinal Chemistry covers all the areas of medicinal chemistry, including developments in rational drug design, bioorganic chemistry, high-throughput screening, combinatorial chemistry, compound diversity measurements, drug absorption, drug distribution, metabolism, new and emerging drug targets, natural products, pharmacogenomics, chemoinformatics, and structure-activity relationships. Medicinal chemistry as a discipline is rapidly maturing. The study of how structure and function are related is absolutely essential to understanding the molecular basis of life. Frontiers in Medicinal Chemistry aims to contribute in a major way to the growth of scientific knowledge and insight, and facilitate the discovery and development of new therapeutic agents to treat debilitating human disorders. This book series is essential for any medicinal chemist who wishes to be kept informed and up-to-date with the latest and the most important advances.
*(Excluding Mailing and Handling)
Secure Checkout Personal information is secured with SSL technology
Editorial promotion: free to download
Pp. iv
Allen B. Reitz, Cheryl P. Kordik, Atta-Ur-Rahman and M. Iqbal Chouhary
Contributors promotion: free to download
Pp. ix-xiv (6)
Atta-ur-Rahman and Allen B. Reitz
Structure and Function of HIV-1 Integrase: An Update
Pp. 3-22 (20)
Thang K. Chiu and David R. Davies
PDF Price: $15
Anti-HIV Drugs and Resistance: Inhibitors of HIV-1 Reverse Transcriptase and Protease
Pp. 23-44 (22)
Tomozumi Imamichi
Gene Therapy for Cardiovascular Diseases
Pp. 59-85 (27)
Marcin Gruchala, Himadri Roy, Shalini Bhardwaj and Seppo Yla-Herttuala
Drug Development and the Importance of Ethnicity: Lessons from Heart Failure Management and Implications for Hypertension
Pp. 45-58 (14)
Michael D. Sosin, Gurbir S. Bhatia, Gregory Y.H. Lip and Russell C. Davis
Design and Discovery of Novel Antihypertensive Drugs Through Conformation and Bioactivity Studies
Pp. 87-111 (25)
Thomas M. Mavromoustakos, Maria V. Zervou and Panagiotis G. Zoumpoulakis
Novel Antiarrhythmic Compounds with Combined Class IB and Class III Mode of Action
Pp. 113-124 (12)
Peter Matyus, Ildiko Varga, Tivadar Rettegi, Antal Simay, Peter Kovacs, Laszlo Karolyhazy, Akos Kocsis, Szilvia Vajda and Andras Va
A1 Adenosine Receptor Agonists: Medicinal Chemistry and Therapeutic Potential
Pp. 125-151 (27)
Sally A. Hutchinson and Peter J. Scammells
Are the Extracellular Pathways a Conduit for the Delivery of Therapeutics to the Brain? Open Access Plus
Pp. 153-161 (9)
William A. Banks
A Review of Neuroprotective Agents
Pp. 163-194 (32)
Margaret A. Brimble and Mark S. Levi
Design of Ligands for the Nicotinic Acetylcholine Receptors: The Quest for Selectivity
Pp. 195-247 (53)
William H. Bunnelle, Michael J. Dart and Michael R. Schrimpf
New Trends in the Design of Drugs Against Alzheimer's Disease
Pp. 249-284 (36)
Pierre Francotte, Pascal de Tullio, Pierre Fraikin and Bernard Pirotte
Development of Melanocortin Receptor Selective Ligands
Pp. 285-334 (50)
Boman G. Irani, Jerry R. Holder, Aleksandar Todorovic, Andrzej M. Wilczynski, Christine G. Joseph, Krista R. Wilson and Carrie Hask
Inhibition of Protein Tyrosine Phosphatase 1B for the Treatment of Diabetes and Obesity
Pp. 335-368 (34)
Zhonghua Pei, Gang Liu, Thomas H. Lubben and Bruce G. Szczepankiewicz
The Impact of Infection on the Incidence of Autoimmune Disease
Pp. 369-382 (14)
Thomas D.C. Thomas, Paola Zaccone, David W. Dunne and Anne Cooke
Transcription Factors in Autoimmune Diseases
Pp. 383-397 (15)
Martin Eggert, Andreas Kluter, Uwe K. Zettl and Gunther Neeck
Small Molecule FLT3 Tyrosine Kinase Inhibitors
Pp. 399-416 (18)
Mark Levis and Donald Small
Potentiality and Limitations of a Strategy for the Control of Cell Proliferation: The Block of Ca2+ Entry
Pp. 417-433 (17)
Luca Munaron, Susanna Antoniotti, Alessandra Fiorio Pla and Davide Lovisolo
An Expanding Appreciation of the Role Chemokine Receptors Play in Cancer Progression
Pp. 435-454 (20)
O. M. Zack Howard and Carole L. Galligan
Structural Bioinformatics and its Impact to Biomedical Science and Drug Discovery
Pp. 455-502 (48)
Kuo-Chen Chou
Recent Advances in Chemical Genomics
Pp. 503-550 (48)
Gyorgy Dorman, Peter Krajcsi, Laszlo G. Puskas, Zoltan Kovari, Zsolt Lorincz, Laszlo Urge and Ferenc Darvas
Predicting Molecular Interactions In Silico: I. An Updated Guide to Pharmacophore Identification and its Applications to Drug Design Open Access Plus
Pp. 551-584 (34)
Oranit Dror, Alexandra Shulman-Peleg, Ruth Nussinov and Haim J. Wolfson
In Silico Methods for Predicting Ligand Binding Determinants of Cytochromes P450
Pp. 615-652 (38)
Marcel J. de Groot, Stewart B. Kirton and Michael J. Sutcliffe
Trends in Hit-to-Lead: An Update
Pp. 653-673 (21)
Benoit Deprez and Rebecca Deprez-Poulain
Recent Development and Application of Virtual Screening in Drug Discovery: An Overview
Pp. 675-703 (29)
Tingjun Hou and Xiaojie Xu
Biology of Heme in Health and Disease
Pp. 705-714 (10)
Nastiti Wijayanti and Stephan Immenschuh
view more
